Table II.
Transmethylation and transsulfuration metabolites in autistic cases and controls
Control* | Autistic* | p value | |
---|---|---|---|
(n=73) | (n=80) | ||
Methionine (µmol/L) | 28.0 ± 6.5 | 20.6 ± 5.2 | <0.0001 |
SAM (nmol/L) | 93.8 ± 18 | 84.3 ± 11 | <0.0001 |
SAH (nmol/L) | 18.8 ± 4.5 | 23.3 ± 7.9 | <0.0001 |
SAM/SAH ratio | 5.5 ± 2.8 | 4.0 ± 1.7 | <0.0001 |
Adenosine (µmol/L) | 0.19 ± 0.13 | 0.28 ± .13 | 0.001 |
Homocysteine (µmol/L) | 6.0 ± 1.3 | 5.7 ± 1.2 | 0.03 |
Cystathionine (µmol/L) | 0.19 ± 0.1 | 0.24 ± 0.1 | <0.0001 |
Cysteine (µmol/L) | 207 ± 22 | 165 ± 14 | <0.0001 |
Cysteinylglycine (µmol/L) | 39.4 ± 7.3 | 38.9 ± 11 | 0.78 |
Total GSH (µmol/L) | 7.53 ± 1.7 | 5.1 ± 1.2 | <0.0001 |
Free GSH (µmol/L | 2.2 ± 0.9 | 1.4 ± 0.5 | <0.0001 |
GSSG (µmol/L) | 0.24 ± 0.1 | 0.40 ± 0.2 | <0.0001 |
Total GSH/GSSG Ratio | 28.2 ± 7.0 | 14.7 ± 6.2 | <0.0001 |
Free GSH/GSSG Ratio | 7.9 ± 3.5 | 4.9 ± 2.2 | <0.0001 |
Means ± SD
Abbreviations: SAM: S-adenosylmethionine; SAH: S-adenosylhomocysteine; GSH: glutathione; GSSG: glutathione disulfide